China National Accord Medicines Corporation Ltd. (000028)
Market Open
10 Aug, 06:57
XSHE XSHE Primary ¥
20. 45
+0.13
+0.6398%
¥
13.96B Market Cap
9.89 P/E Ratio
2.72% Div Yield
4.09M Volume
2.96 Eps
¥ 20.32
Previous Close Want to track 000028 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
000028 trading today higher at ¥20.45, an increase of 0.6398% from yesterday's close, completing a monthly increase of 8.0867% or ¥1.53. Over the past 12 months, 000028 stock lost -16.7006%.
000028 pays dividends to its shareholders, with the most recent payment made on Jun 24, 2026. The next estimated payment will be in In 10 months on Jun 24, 2027 for a total of ¥0.6776.
The last earnings report, released on Apr 02, 2026, missed the consensus estimates by -0.46%. On average, the company has fell short of earnings expectations by -0.1667%, based on the last three reports.
China National Accord Medicines Corporation Ltd. has completed 7 stock splits, with the recent split occurring on Jun 24, 2026.
The company's stock is traded on one exchange.
000028 Chart
People also search for
China National Accord Medicines Corporation Ltd. (000028) FAQ
What is the stock price today?
The current price is ¥20.45.
On which exchange is it traded?
China National Accord Medicines Corporation Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 000028.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 2.72%.
What is its market cap?
As of today, the market cap is 13.96B.
Has China National Accord Medicines Corporation Ltd. ever had a stock split?
China National Accord Medicines Corporation Ltd. had 7 splits and the recent split was on Jun 24, 2026.
China National Accord Medicines Corporation Ltd. Profile
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Mr. Zhaoxiong Lin MBA CEO | XSHE Exchange | CNE0000009N6 ISIN |
| CN Country | - Employees | 24 Jun 2026 Last Dividend | 24 Jun 2026 Last Split | 5 May 1993 IPO Date |
Overview
China National Accord Medicines Corporation Ltd., with a global reach, is a significant player in the pharmaceutical industry, primarily focusing on the retail and distribution of pharmaceutical products. Originating in 1993 and having its headquarters in Shenzhen, China, the company has evolved considerably from its early days as Shenzhen Health Mineral Water Corp., Ltd. It operates under the umbrella of Sinopharm Group Co., Ltd., reflecting its influential position within China’s pharmaceutical sector. The company's broad array of services caters to various healthcare and commercial needs, indicating its diversified approach to business.
Products and Services
The extensive range of products and services offered by China National Accord Medicines Corporation Ltd. encompasses the healthcare industry's needs while also extending into other areas. Each category reveals the company's commitment to providing comprehensive solutions:
- Pharmaceutical Products: This includes a wide variety of drugs, such as proprietary Chinese medicines, chemical preparations, antibiotics, biochemical drugs, and biological preparations. The company's pharmaceutical portfolio is designed to meet the diverse needs of the healthcare sector.
- Medical Equipment: In addition to medications, the company retail and distributes medical devices, supporting healthcare providers with essential tools for patient care.
- Cargo Transportation and Warehousing: Recognizing the importance of logistics in healthcare, China National Accord Medicines offers services in cargo transportation, warehousing, loading, and unloading, ensuring efficient delivery and storage of medical supplies and equipment.
- Consulting and Agency Services: The company provides professional consulting and acts as an agent for the import and export of various commodities and technologies, facilitating global trade in the healthcare sector.
- Consumer Goods: Beyond healthcare, China National Accord Medicines extends its services to the retail of daily necessities, glass instruments, cosmetics, and health supplies, catering to general consumer needs.
- Leasing Services: House leasing services are offered, indicating the company's foray into real estate, which complements its diversified service offerings.
- Import and Export: The company is actively involved in the import and export of a broad spectrum of products, including therapeutic and diagnostic biological products, stereotyped packaged foods, chemical products, as well as self-management and agency of various commodities and technologies. This global trading capability highlights the company’s expansive operational scope.
Contact Information
Address: Accord Pharmaceutical Building, Shenzhen, China, 518029
Phone: 86 755 2587 5140
Website: https://www.szaccord.com.cn
